These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 26915368)

  • 1. Hybridizing LBA with LC-MS/MS: the new norm for biologics quantification.
    Ramagiri S; Moore I
    Bioanalysis; 2016 Mar; 8(6):483-6. PubMed ID: 26915368
    [No Abstract]   [Full Text] [Related]  

  • 2. Generic Hybrid Ligand Binding Assay Liquid Chromatography High-Resolution Mass Spectrometry-Based Workflow for Multiplexed Human Immunoglobulin G1 Quantification at the Intact Protein Level: Application to Preclinical Pharmacokinetic Studies.
    Lanshoeft C; Cianférani S; Heudi O
    Anal Chem; 2017 Feb; 89(4):2628-2635. PubMed ID: 28192936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Techniques for quantitative LC-MS/MS analysis of protein therapeutics: advances in enzyme digestion and immunocapture.
    Fung EN; Bryan P; Kozhich A
    Bioanalysis; 2016 Apr; 8(8):847-56. PubMed ID: 27005854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LC-MS quantification of protein drugs: validating protein LC-MS methods with predigestion immunocapture.
    Duggan J; Ren B; Mao Y; Chen LZ; Philip E
    Bioanalysis; 2016 Sep; 8(18):1951-64. PubMed ID: 27532431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitation of human peptides and proteins via MS: review of analytically validated assays.
    Chappell DL; Lassman ME; McAvoy T; Lin M; Spellman DS; Laterza OF
    Bioanalysis; 2014; 6(13):1843-57. PubMed ID: 25157489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calculated conjugated payload from immunoassay and LC-MS intact protein analysis measurements of antibody-drug conjugate.
    Rago B; Clark T; King L; Zhang J; Tumey LN; Li F; Barletta F; Wei C; Leal M; Hansel S; Han X
    Bioanalysis; 2016 Nov; 8(21):2205-2217. PubMed ID: 27682846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generic automated method for liquid chromatography-multiple reaction monitoring mass spectrometry based monoclonal antibody quantitation for preclinical pharmacokinetic studies.
    Zhang Q; Spellman DS; Song Y; Choi B; Hatcher NG; Tomazela D; Beaumont M; Tabrizifard M; Prabhavalkar D; Seghezzi W; Harrelson J; Bateman KP
    Anal Chem; 2014 Sep; 86(17):8776-84. PubMed ID: 25010922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can LC-MS/MS and ligand-binding assays live in harmony for large-molecule bioanalysis?
    Papadimitriou A; Bansal S; Heinrich J; Staack RF
    Bioanalysis; 2014; 6(13):1735-7. PubMed ID: 25157480
    [No Abstract]   [Full Text] [Related]  

  • 9. Validation of LC-MS/MS bioanalytical methods for protein therapeutics.
    Vazvaei F; Duggan JX
    Bioanalysis; 2014; 6(13):1739-42. PubMed ID: 25157481
    [No Abstract]   [Full Text] [Related]  

  • 10. A multiplexed hybrid LC-MS/MS pharmacokinetic assay to measure two co-administered monoclonal antibodies in a clinical study.
    Xu K; Liu L; Maia M; Li J; Lowe J; Song A; Kaur S
    Bioanalysis; 2014; 6(13):1781-94. PubMed ID: 25157485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. General LC-MS/MS method approach to quantify therapeutic monoclonal antibodies using a common whole antibody internal standard with application to preclinical studies.
    Li H; Ortiz R; Tran L; Hall M; Spahr C; Walker K; Laudemann J; Miller S; Salimi-Moosavi H; Lee JW
    Anal Chem; 2012 Feb; 84(3):1267-73. PubMed ID: 22243404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the potential use of hybrid LC-MS/MS for active drug quantification applying the 'free analyte QC concept'.
    Jordan G; Onami I; Heinrich J; Staack RF
    Bioanalysis; 2017 Nov; 9(21):1705-1717. PubMed ID: 28952783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress in high-sensitivity hybrid LC-MS/MS methods for the bioanalysis of protein drugs and performance tests for their validation.
    Duggan JX
    Bioanalysis; 2018 Jul; 10(13):983-986. PubMed ID: 29993264
    [No Abstract]   [Full Text] [Related]  

  • 14. Protein quantification by LC-MS: a decade of progress through the pages of
    van de Merbel NC
    Bioanalysis; 2019 Apr; 11(7):629-644. PubMed ID: 30983409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IQ consortium perspective: complementary LBA and LC-MS in protein therapeutics bioanalysis and biotransformation assessment.
    Kaur S; Bateman KP; Glick J; Jairaj M; F Kellie J; Sydor J; Zeng J
    Bioanalysis; 2020 Feb; 12(4):257-270. PubMed ID: 32096432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical considerations for immunocapture enrichment LC-MS bioanalysis of protein therapeutics and biomarkers.
    Zhao Y; Gu H; Zheng N; Zeng J
    Bioanalysis; 2018 Jul; 10(13):987-995. PubMed ID: 29972311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of biotherapeutic targets: new opportunities with immunoaffinity LC-MS/MS.
    Neubert H; Palandra J; Fernández Ocaña M
    Bioanalysis; 2014; 6(13):1731-3. PubMed ID: 25157479
    [No Abstract]   [Full Text] [Related]  

  • 18. Application of high-resolution MS in the quantification of a therapeutic monoclonal antibody in human plasma.
    Mekhssian K; Mess JN; Garofolo F
    Bioanalysis; 2014; 6(13):1767-79. PubMed ID: 25157484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of matrix effects in LC-MS/MS bioanalysis.
    Bergeron A; Garofolo F
    Bioanalysis; 2013 Oct; 5(19):2331-2. PubMed ID: 24066616
    [No Abstract]   [Full Text] [Related]  

  • 20. A whole-molecule immunocapture LC-MS approach for the in vivo quantitation of biotherapeutics.
    Kellie JF; Kehler JR; Mencken TJ; Snell RJ; Hottenstein CS
    Bioanalysis; 2016 Oct; 8(20):2103-14. PubMed ID: 27611496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.